The U.S. Food and Drug Administration approved Amgen’s biosimilar version of AbbVie’s top-selling arthritis drug Humira.
Endo International Plc said Chief Executive Rajiv De Silva had stepped down and would be replaced by generics division head Paul Campanelli.
Six international health experts, including four from Europe, are to compete to become the next director general of the World Health Organization (WHO) after its current leader Margaret Chan ends her tenure in June 2017.
United Parcel Service Inc. said it began testing the use of drones for emergency deliveries of medical supplies with a flight in rural Massachusetts, which the company hopes will eventually lead to federal approval of drones as a regular delivery option.
Novartis’ Zykadia drug performed well against a rare form of lung cancer, citing a study the Swiss company hopes will help it win expanded regulatory approval.
The months-long drama involving Sarepta Therapeutics’ eteplilrsen for Duchenne Muscular Dystrophy (DMD) and the U.S. Food and Drug Administration is not over, despite the drug’s accelerated approval.
Danish company H. Lundbeck A/S announced its experimental Alzheimer’s treatment idalopirdine failed in a late-stage trial.
Thirty-five U.S. states and the District of Columbia filed a lawsuit against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market.
Emerging markets have lost their luster for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building.